SANKAR NAVANEETHAN to Glucagon-Like Peptide 1
This is a "connection" page, showing publications SANKAR NAVANEETHAN has written about Glucagon-Like Peptide 1.
Connection Strength
0.270
-
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Curr Opin Nephrol Hypertens. 2024 05 01; 33(3):331-336.
Score: 0.222
-
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). Am J Cardiol. 2022 06 01; 172:7-10.
Score: 0.049